SDY News and Press, SPDR S&P Dividend From 05/20/22

Large-cap growth stocks outperformed small-cap value stocks by over 700 basis points (bps) annualized from 2012 to 2021. This stretch of whopping outperformance - a cumulative gain of 508% for large growth versus 211% for small value - stands in stark contrast to the findings of acade...

UGI currently offers a 3.5% forward yield, which is a historically very appealing starting yield. With the recent 4.3% dividend hike, the company now boasts 35 consecutive years of dividend hikes and maintains a 50% payout ratio on a FCF basis. Short-term volatility in inflation, ...

Nu Skin beat top and bottom line estimates in Q1. Growth though is on the wane. We are plugging for the transition strategy to come good. Nu Skin will need external trading conditions to align accordingly. For further details see: Nu Skin: Hoping Any Potential Downturn W...

For the fourth straight month, mutual fund investors were net redeemers of fund assets, withdrawing $159.7 billion from conventional funds for April. Fixed income funds (-$43.5 billion for April) witnessed net outflows for the fifth month in a row, while money market funds (-$70.6 bil...

Investing conservatively is how the aging investor population needs to approach the stock market. The reality is once you have mastered something or have a strategy to follow, the process can feel relatively slow, dull, and boring. With bonds currently in a bear market, we need to...

The rising rate, rising dollar environment continues with the dollar index hitting a 20-year high last week. That rising dollar is having an impact on the rest of the global economy but so far it has been manageable. There are a lot of companies out there that have come public over th...

Value continues to trounce growth stocks within the style asset class across all market caps, and the longer-term returns tell us that growth might continue to lag for some time. It’s impossible to say how long the style “alpha” will be sustained. Growth stocks ha...

Net premiums are growing without issue in a catastrophe-free year across segments. Some are seeing higher competition, but most of the big growth areas of last quarter are open to pricing flex. Market volatility is hurting current book values, but a higher rate environment will be...

Markets have been selling-off. This is understandably making investors nervous. In this review, I take a look at some actions we can take now. This sell-off has been broad and painful, with few places to shelter. This represents opportunity, but also acts as a sign of caution that cor...

The CDC ETF combines fundamental criteria to select dividend stocks with a volatility weighting methodology. The fund has delivered a positive return thus far in 2022, bucking the trend of the broad market selloff. CDC is a high-quality strategy ETF that can represent a defensive ...